(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one

DB07430ExperimentalSmall molecule

(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one: Overview.

Mechanism: Pharmacologically active on MAP kinase-activated protein kinase 2
Curator reviewed
Formula / weight: C₂₁H₁₈N₄OS · 374.459 g/mol (avg)

Resolves to

Compound

UNIIN4H5CH3E5SChEMBLCHEMBL1231206PubChem44631903

Structure

InChIKeyCMWRPDHVGMHLSZ-GFCCVEGCSA-NSMILES[H][C@@]1(C)CNC2=C(SC3=C2C2=C(C=C3)N=C(C=C2)C2=CN=C(C)C=C2)C(=O)N1

Targets

P49137MAPKAPK2

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account